We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Pathology

Image: Genetic Overlap Found for Ovarian Cancer Subtypes and Endometriosis (Photo courtesy of University of Queensland)

Genetic Overlap Found for Ovarian Cancer Subtypes and Endometriosis (Cell Reports Medicine: University of Queensland)

A research team in Australia, the US, and the UK has delved into genetic ties between specific epithelial ovarian cancer (EOC) histotypes and endometriosis, a condition previously associated with enhanced EOC risk. More...
22 Mar 2022
Image: The Cellometer K2 utilizes brightfield imaging and dual-fluorescence imaging to quickly and accurately identify and count individual cells. Cell count, concentration, diameter, and % viability are automatically calculated and reported (Photo courtesy of Nexcelom Bioscience)

Single Cell Characterization Acral Melanoma Identifies Novel Targets for Immunotherapy

Acral melanoma is a rare subtype that represents roughly 3% of all melanoma cases. Unlike typical melanoma that occurs on sun-exposed skin, acral melanoma develops on the nonhair bearing skin of the soles, palm and nail beds. There is very little information known about the development of acral melanoma. More...
16 Mar 2022
Image: Visualizing the invisible: New fluorescent DNA label reveals nanoscopic cancer features using a custom-built system on the Olympus IX71 Inverted Microscope (Photo courtesy of Fluorescence Microscopes)

New Fluorescent DNA Label Reveals Nanoscopic Cancer Features

Researchers have developed a new fluorescent label that gives a clearer picture of how DNA architecture is disrupted in cancer cells. The findings could improve cancer diagnoses for patients and classification of future cancer risk. More...
15 Mar 2022
Image: AI software reads unstructured data sources & ID at-risk cancer patients (Photo courtesy of Azra AI)

AI Platform Identifies 99% of Positive Cancer Cases in Pathology Reports

A new artificial intelligence (AI) platform disrupts the manual and repetitive processes in healthcare to identify positive cancer diagnosis and incidental findings in real time, classify those diagnoses by primary site, and route those patients to cancer navigators and other staff to immediately start the cancer care journey. More...
14 Mar 2022
Image: The Chemagic Magnetic Separation Module I is the complete solution for preparation of nucleic acids from various sample material, such as blood, tissue, bacteria, plasma, saliva etc. (Photo courtesy of PerkinElmer Chemagen Technologie)

Inherited Cancer Risk Detected in Significant Subset of Wilms Tumor Cases

Roughly one in every three children with a type of kidney cancer known as Wilms tumor, or nephroblastoma, carry germline alterations implicated in hereditary cancer risk, new research suggests — findings that have prompted more widespread genetic testing for Dutch children with the condition. More...
08 Mar 2022
Image: Photomicrograph of cytomegalovirus colitis (Photo courtesy of Nephron)

Immunohistochemistry Evaluated for Tissue-Invasive Cytomegalovirus in Gastrointestinal Mucosal Biopsies

Cytomegalovirus (CMV) immunohistochemistry (IHC) is the most widely used method to diagnose CMV infection/reactivation in tissues in a pathology laboratory. More...
04 Mar 2022
Image: Strong nuclear and cytoplasmic p16 staining of a section from an HPV+ oropharynx tumor. Lymphocytes (blue arrow) and endothelial cells (black arrow) are unstained (Photo courtesy of Jonathon McHugh, MD)

TTMV-HPV DNA Biomarker Predicts Recurrence of Oropharynx Cancer

A large, multi-institutional study demonstrates that a blood test to detect circulating tumor DNA can accurately predict recurrence of HPV-driven oropharyngeal cancer following treatment. Results also indicate that the biomarker test may detect recurrent disease earlier than imaging or other standard methods of post-treatment surveillance, allowing physicians to personalize treatment more quickly for patients whose cancer returns. More...
03 Mar 2022
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Mini Vortex Mixer
Vornado
New
C-Reactive Protein Rapid Test
Afinion CRP


The Pathology channel details advances in the field of Surgical Pathology and all its subspecialties, including Cytopathology and its subspecialties.